Does Patient Education Decrease Readmission Rates for Asthmatic Children in the Developed Countries?

Cite this:
[1]
Saleh Albalawi, “Does Patient Education Decrease Readmission Rates for Asthmatic Children in the Developed Countries?”, ijmhs, vol. 10, no. 06, pp. 1066–1079, Jun. 2020.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
562
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF  

Abstract

Asthma is a chronic inflammatory condition that affects the airways. The features of the disease include narrowing of the airways, recurrent episodes of breathlessness, chest tightness and wheezing. The condition is one of the most common chronic illness in not only children but also in adults and aged individuals (Asthma Australia 2017). In Australia, the prevalence of Asthma among children is among the highest across the globe. One out of every nine Australians suffers from asthma. The condition is more common among males aged between 0-14, but more common among females aged 15 years and over. The disease is prevalent among individuals living in poor neighbourhoods and rural areas. Every person living with asthma should have a written action plan. However, only people aged 15 and over have a written action plan (Asthma Australia 2017). Only 41% of children who have developed the condition have an action plan (Asthma Australia 2017). In the United States, over 23 million individuals have the condition, with children projected to be about 6.8 million, or rather, an average of 1 out of every 10 school aged children (McCarty and Rogers 2012).

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”